7
|
Sadakata T, Washida M, Iwayama Y, Shoji S, Sato Y, Ohkura T, Katoh-Semba R, Nakajima M, Sekine Y, Tanaka M, Nakamura K, Iwata Y, Tsuchiya KJ, Mori N, Detera-Wadleigh SD, Ichikawa H, Itohara S, Yoshikawa T, Furuichi T. Autistic-like phenotypes in Cadps2-knockout mice and aberrant CADPS2 splicing in autistic patients. J Clin Invest 2007; 117:931-43. [PMID: 17380209 PMCID: PMC1821065 DOI: 10.1172/jci29031] [Citation(s) in RCA: 168] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2006] [Accepted: 01/16/2007] [Indexed: 12/15/2022] Open
Abstract
Autism, characterized by profound impairment in social interactions and communicative skills, is the most common neurodevelopmental disorder, and its underlying molecular mechanisms remain unknown. Ca(2+)-dependent activator protein for secretion 2 (CADPS2; also known as CAPS2) mediates the exocytosis of dense-core vesicles, and the human CADPS2 is located within the autism susceptibility locus 1 on chromosome 7q. Here we show that Cadps2-knockout mice not only have impaired brain-derived neurotrophic factor release but also show autistic-like cellular and behavioral phenotypes. Moreover, we found an aberrant alternatively spliced CADPS2 mRNA that lacks exon 3 in some autistic patients. Exon 3 was shown to encode the dynactin 1-binding domain and affect axonal CADPS2 protein distribution. Our results suggest that a disturbance in CADPS2-mediated neurotrophin release contributes to autism susceptibility.
Collapse
Affiliation(s)
- Tetsushi Sadakata
- Laboratory for Molecular Neurogenesis and Laboratory
for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
Tokyo Metropolitan Umegaoka Hospital, Tokyo, Japan.
Department of Perinatology, Institute for Developmental Research,
Aichi Human Service Center, Kasugai, Japan. Research Resource
Center, RIKEN Brain Science Institute, Saitama, Japan. Department of
Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Mood and Anxiety Disorders Program, National Institute of Mental
Health, Bethesda, Maryland, USA. Laboratory for Behavioral Genetics,
RIKEN Brain Science Institute, Saitama, Japan
| | - Miwa Washida
- Laboratory for Molecular Neurogenesis and Laboratory
for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
Tokyo Metropolitan Umegaoka Hospital, Tokyo, Japan.
Department of Perinatology, Institute for Developmental Research,
Aichi Human Service Center, Kasugai, Japan. Research Resource
Center, RIKEN Brain Science Institute, Saitama, Japan. Department of
Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Mood and Anxiety Disorders Program, National Institute of Mental
Health, Bethesda, Maryland, USA. Laboratory for Behavioral Genetics,
RIKEN Brain Science Institute, Saitama, Japan
| | - Yoshimi Iwayama
- Laboratory for Molecular Neurogenesis and Laboratory
for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
Tokyo Metropolitan Umegaoka Hospital, Tokyo, Japan.
Department of Perinatology, Institute for Developmental Research,
Aichi Human Service Center, Kasugai, Japan. Research Resource
Center, RIKEN Brain Science Institute, Saitama, Japan. Department of
Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Mood and Anxiety Disorders Program, National Institute of Mental
Health, Bethesda, Maryland, USA. Laboratory for Behavioral Genetics,
RIKEN Brain Science Institute, Saitama, Japan
| | - Satoshi Shoji
- Laboratory for Molecular Neurogenesis and Laboratory
for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
Tokyo Metropolitan Umegaoka Hospital, Tokyo, Japan.
Department of Perinatology, Institute for Developmental Research,
Aichi Human Service Center, Kasugai, Japan. Research Resource
Center, RIKEN Brain Science Institute, Saitama, Japan. Department of
Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Mood and Anxiety Disorders Program, National Institute of Mental
Health, Bethesda, Maryland, USA. Laboratory for Behavioral Genetics,
RIKEN Brain Science Institute, Saitama, Japan
| | - Yumi Sato
- Laboratory for Molecular Neurogenesis and Laboratory
for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
Tokyo Metropolitan Umegaoka Hospital, Tokyo, Japan.
Department of Perinatology, Institute for Developmental Research,
Aichi Human Service Center, Kasugai, Japan. Research Resource
Center, RIKEN Brain Science Institute, Saitama, Japan. Department of
Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Mood and Anxiety Disorders Program, National Institute of Mental
Health, Bethesda, Maryland, USA. Laboratory for Behavioral Genetics,
RIKEN Brain Science Institute, Saitama, Japan
| | - Takeshi Ohkura
- Laboratory for Molecular Neurogenesis and Laboratory
for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
Tokyo Metropolitan Umegaoka Hospital, Tokyo, Japan.
Department of Perinatology, Institute for Developmental Research,
Aichi Human Service Center, Kasugai, Japan. Research Resource
Center, RIKEN Brain Science Institute, Saitama, Japan. Department of
Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Mood and Anxiety Disorders Program, National Institute of Mental
Health, Bethesda, Maryland, USA. Laboratory for Behavioral Genetics,
RIKEN Brain Science Institute, Saitama, Japan
| | - Ritsuko Katoh-Semba
- Laboratory for Molecular Neurogenesis and Laboratory
for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
Tokyo Metropolitan Umegaoka Hospital, Tokyo, Japan.
Department of Perinatology, Institute for Developmental Research,
Aichi Human Service Center, Kasugai, Japan. Research Resource
Center, RIKEN Brain Science Institute, Saitama, Japan. Department of
Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Mood and Anxiety Disorders Program, National Institute of Mental
Health, Bethesda, Maryland, USA. Laboratory for Behavioral Genetics,
RIKEN Brain Science Institute, Saitama, Japan
| | - Mizuho Nakajima
- Laboratory for Molecular Neurogenesis and Laboratory
for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
Tokyo Metropolitan Umegaoka Hospital, Tokyo, Japan.
Department of Perinatology, Institute for Developmental Research,
Aichi Human Service Center, Kasugai, Japan. Research Resource
Center, RIKEN Brain Science Institute, Saitama, Japan. Department of
Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Mood and Anxiety Disorders Program, National Institute of Mental
Health, Bethesda, Maryland, USA. Laboratory for Behavioral Genetics,
RIKEN Brain Science Institute, Saitama, Japan
| | - Yukiko Sekine
- Laboratory for Molecular Neurogenesis and Laboratory
for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
Tokyo Metropolitan Umegaoka Hospital, Tokyo, Japan.
Department of Perinatology, Institute for Developmental Research,
Aichi Human Service Center, Kasugai, Japan. Research Resource
Center, RIKEN Brain Science Institute, Saitama, Japan. Department of
Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Mood and Anxiety Disorders Program, National Institute of Mental
Health, Bethesda, Maryland, USA. Laboratory for Behavioral Genetics,
RIKEN Brain Science Institute, Saitama, Japan
| | - Mika Tanaka
- Laboratory for Molecular Neurogenesis and Laboratory
for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
Tokyo Metropolitan Umegaoka Hospital, Tokyo, Japan.
Department of Perinatology, Institute for Developmental Research,
Aichi Human Service Center, Kasugai, Japan. Research Resource
Center, RIKEN Brain Science Institute, Saitama, Japan. Department of
Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Mood and Anxiety Disorders Program, National Institute of Mental
Health, Bethesda, Maryland, USA. Laboratory for Behavioral Genetics,
RIKEN Brain Science Institute, Saitama, Japan
| | - Kazuhiko Nakamura
- Laboratory for Molecular Neurogenesis and Laboratory
for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
Tokyo Metropolitan Umegaoka Hospital, Tokyo, Japan.
Department of Perinatology, Institute for Developmental Research,
Aichi Human Service Center, Kasugai, Japan. Research Resource
Center, RIKEN Brain Science Institute, Saitama, Japan. Department of
Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Mood and Anxiety Disorders Program, National Institute of Mental
Health, Bethesda, Maryland, USA. Laboratory for Behavioral Genetics,
RIKEN Brain Science Institute, Saitama, Japan
| | - Yasuhide Iwata
- Laboratory for Molecular Neurogenesis and Laboratory
for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
Tokyo Metropolitan Umegaoka Hospital, Tokyo, Japan.
Department of Perinatology, Institute for Developmental Research,
Aichi Human Service Center, Kasugai, Japan. Research Resource
Center, RIKEN Brain Science Institute, Saitama, Japan. Department of
Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Mood and Anxiety Disorders Program, National Institute of Mental
Health, Bethesda, Maryland, USA. Laboratory for Behavioral Genetics,
RIKEN Brain Science Institute, Saitama, Japan
| | - Kenji J. Tsuchiya
- Laboratory for Molecular Neurogenesis and Laboratory
for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
Tokyo Metropolitan Umegaoka Hospital, Tokyo, Japan.
Department of Perinatology, Institute for Developmental Research,
Aichi Human Service Center, Kasugai, Japan. Research Resource
Center, RIKEN Brain Science Institute, Saitama, Japan. Department of
Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Mood and Anxiety Disorders Program, National Institute of Mental
Health, Bethesda, Maryland, USA. Laboratory for Behavioral Genetics,
RIKEN Brain Science Institute, Saitama, Japan
| | - Norio Mori
- Laboratory for Molecular Neurogenesis and Laboratory
for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
Tokyo Metropolitan Umegaoka Hospital, Tokyo, Japan.
Department of Perinatology, Institute for Developmental Research,
Aichi Human Service Center, Kasugai, Japan. Research Resource
Center, RIKEN Brain Science Institute, Saitama, Japan. Department of
Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Mood and Anxiety Disorders Program, National Institute of Mental
Health, Bethesda, Maryland, USA. Laboratory for Behavioral Genetics,
RIKEN Brain Science Institute, Saitama, Japan
| | - Sevilla D. Detera-Wadleigh
- Laboratory for Molecular Neurogenesis and Laboratory
for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
Tokyo Metropolitan Umegaoka Hospital, Tokyo, Japan.
Department of Perinatology, Institute for Developmental Research,
Aichi Human Service Center, Kasugai, Japan. Research Resource
Center, RIKEN Brain Science Institute, Saitama, Japan. Department of
Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Mood and Anxiety Disorders Program, National Institute of Mental
Health, Bethesda, Maryland, USA. Laboratory for Behavioral Genetics,
RIKEN Brain Science Institute, Saitama, Japan
| | - Hironobu Ichikawa
- Laboratory for Molecular Neurogenesis and Laboratory
for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
Tokyo Metropolitan Umegaoka Hospital, Tokyo, Japan.
Department of Perinatology, Institute for Developmental Research,
Aichi Human Service Center, Kasugai, Japan. Research Resource
Center, RIKEN Brain Science Institute, Saitama, Japan. Department of
Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Mood and Anxiety Disorders Program, National Institute of Mental
Health, Bethesda, Maryland, USA. Laboratory for Behavioral Genetics,
RIKEN Brain Science Institute, Saitama, Japan
| | - Shigeyoshi Itohara
- Laboratory for Molecular Neurogenesis and Laboratory
for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
Tokyo Metropolitan Umegaoka Hospital, Tokyo, Japan.
Department of Perinatology, Institute for Developmental Research,
Aichi Human Service Center, Kasugai, Japan. Research Resource
Center, RIKEN Brain Science Institute, Saitama, Japan. Department of
Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Mood and Anxiety Disorders Program, National Institute of Mental
Health, Bethesda, Maryland, USA. Laboratory for Behavioral Genetics,
RIKEN Brain Science Institute, Saitama, Japan
| | - Takeo Yoshikawa
- Laboratory for Molecular Neurogenesis and Laboratory
for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
Tokyo Metropolitan Umegaoka Hospital, Tokyo, Japan.
Department of Perinatology, Institute for Developmental Research,
Aichi Human Service Center, Kasugai, Japan. Research Resource
Center, RIKEN Brain Science Institute, Saitama, Japan. Department of
Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Mood and Anxiety Disorders Program, National Institute of Mental
Health, Bethesda, Maryland, USA. Laboratory for Behavioral Genetics,
RIKEN Brain Science Institute, Saitama, Japan
| | - Teiichi Furuichi
- Laboratory for Molecular Neurogenesis and Laboratory
for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan.
Tokyo Metropolitan Umegaoka Hospital, Tokyo, Japan.
Department of Perinatology, Institute for Developmental Research,
Aichi Human Service Center, Kasugai, Japan. Research Resource
Center, RIKEN Brain Science Institute, Saitama, Japan. Department of
Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Mood and Anxiety Disorders Program, National Institute of Mental
Health, Bethesda, Maryland, USA. Laboratory for Behavioral Genetics,
RIKEN Brain Science Institute, Saitama, Japan
| |
Collapse
|